Seres Therapeutics Inc — Quarterly Cash Flow (NASDAQ:MCRB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 139.81 M164.18 M143.8 M143.47 M138.19 M Total liabilities 126.03 M113.72 M110.85 M99.78 M93.97 M Total equity 13.78 M50.47 M32.95 M43.7 M44.22 M Total liabilities & shareholders' equities 139.81 M164.18 M143.8 M143.47 M138.19 M Total debt 0———— Net debt -30.79 M————

News

Seres Therapeutics schedules 2026 annual meeting for June 9

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres to present new data on SER-155 bloodstream infection study

Seres Therapeutics announces workforce reduction to extend cash runway

Factbox-More companies adopt co-CEO structure

Canaccord Genuity raises Seres Therapeutics stock price target to $22 on FDA hopes

Seres Therapeutics advances SER-155 protocol after FDA feedback